Use Of 3,4-Diaminopyridine (3,4-DAP) In The Treatment Of Lambert Eaton Myasthenic Syndrome
Clinical trial NCT01373333 · NO_LONGER_AVAILABLE
Trial details
- NCT number
- NCT01373333
- Sponsor
- The Cleveland Clinic
- Status
- NO_LONGER_AVAILABLE
- Study type
- EXPANDED_ACCESS
- Start date
- 1997-09-01
- Primary completion
- 2012-09-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.